|
Clinical summary |
||||||||
| Individual |
Gender |
First symptoms |
Disease duration |
APOE genotype |
Clinical presentation |
|||
| (years) |
(years) |
Psychosis |
FTD |
ALS |
Dementia* |
|||
|
|
||||||||
| II-2 |
M |
~45 |
~18 |
- |
+ |
- |
- |
|
| III-3 |
M |
~59 |
~7 |
e3/e4 |
- |
+ # |
- |
- |
| III-5 |
F |
~45 |
~11 |
- |
+ |
- |
- |
|
| III-7 |
F |
~59 |
2 (alive) |
e3/e4 |
- |
+ |
- |
- |
| IV-1 |
F |
43 |
3 (alive) |
e3/e4 |
- |
+ |
- |
- |
| II-5 |
F |
63 |
1 |
- |
+ |
+ |
- |
|
| III-6 |
M |
58 |
3 (alive) |
e4/e4 |
+ |
+ |
+ |
- |
| III-8 |
F |
46 |
4 |
e2/e4 |
+ |
- |
+ |
- |
| III-12 |
M |
46 |
5 |
e4/e4 |
- |
- |
+ # |
- |
| III-2 |
F |
68 |
7 |
e3/e4 |
- |
- |
- |
+ # |
| II-7 |
F |
50 |
16 |
- |
- |
- |
+ |
|
|
* Refer to the text for details. # Diagnosis confirmed by neuropathological examination | ||||||||
Luty et al. BMC Neurology 2008 8:32 doi:10.1186/1471-2377-8-32 |
||||||||